The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B
Open Access
- 12 March 2025
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (4) , 100029
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (T32 GM007635)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (F31 NS129254, R01 NS118786, R01 NS081248)
- National Institute on Aging (R01 AG067713)
This publication has 44 references indexed in Scilit:
- Ligand‐induced CaMKIIα hub Trp403 flip, hub domain stacking, and modulation of kinase activityProtein Science, 2024
- Characterization of CaMKIIα holoenzyme stabilityProtein Science, 2020
- CaMKII versus DAPK1 Binding to GluN2B in Ischemic Neuronal Cell Death after Resuscitation from Cardiac ArrestCell Reports, 2020
- Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer’s-Related Plasticity ImpairmentCell Reports, 2019
- Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular CondensatesCell, 2019
- DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP SpecificCell Reports, 2017
- Autonomous CaMKII Activity as a Drug Target for Histological and Functional Neuroprotection after Resuscitation from Cardiac ArrestCell Reports, 2017
- Autonomous CaMKII Mediates Both LTP and LTD Using a Mechanism for Differential Substrate Site SelectionCell Reports, 2014
- Dual role of calmodulin in autophosphorylation of multifunctional cam kinase may underlie decoding of calcium signalsNeuron, 1994
- Regulation of brain Type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: A Ca2+-triggered molecular switchCell, 1986